Millennium Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Millennium Management's IBB Position: Q3 2026 in Review
Millennium Management reduced its iShares Biotechnology ETF (IBB) stake by 88% in Q3 2026, selling an estimated $9.14M and leaving 6,412 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #4236.
Millennium Management first reported a position in IBB in Q4 2013 and has held it in 47 quarters since. The position peaked at $86M in Q2 2021. 1,024 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Millennium Management held 6,412 shares of iShares Biotechnology ETF worth $1.35M as of Q3 2026.
- Millennium Management sold 45,562 iShares Biotechnology ETF shares in Q3 2026, an estimated $9.14M.
- iShares Biotechnology ETF made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #4236 holding.
- Millennium Management first reported a position in iShares Biotechnology ETF in Q4 2013 and has held it in 47 quarters since.
- Millennium Management's iShares Biotechnology ETF position peaked at $86M in Q2 2021.
- 1,024 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.